Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion

Life Sciences

Volumn 78, Issue 19, 2006, Pages 2255-2264

  Liu, Xiaoming ^a   Xie, Weiying ^a   Liu, Pichu ^a   Duan, Manlin ^a   Jia, Zhen ^a   Li, Wei ^a   Xu, Jianguo ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

AP 1; Erythropoietin; IL 10; Ischemia reperfusion; NF B

Indexed keywords

CYTOKINE; EVANS BLUE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; RECOMBINANT ERYTHROPOIETIN; TRANSCRIPTION FACTOR AP 1; TRIPHENYLTETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CELL ADHESION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART PROTECTION; IN VIVO STUDY; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MALE; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHIL INFILTRATION; NUCLEAR PROTEINS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 33645210680     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.09.053     Document Type: Article

References (35)

1. D. Agnello, P. Bigini, P. Villa, T. Mennini, A. Cerami, M.L. Brines, and P. Ghezzi Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis Brain Research 952 1 2002 128 134
2. D. Altavilla, F. Squadrito, G.M. Campo, A. Saitta, G. Squadrito, C. Quartarone, B. Deodato, M. Arlotta, M. Ferlito, L. Minutoli, M. Tringali, G. Urna, A. Sardella, and A.P. Caputi The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 Life Sciences 67 21 2000 2615 2629
3. S. Bergelson, U. Klingmuller, M. Socolovsky, J.G. Hsiao, and H.F. Lodish Tyrosine residues within the intracellular domain of the erythropoietin receptor mediate activation of AP-1 transcription factors Journal of Biological Chemistry 273 4 1998 2396 2401
4. T. Bittorf, T. Buchse, R. Jaster, and J. Brock Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance Cell Signalling 13 9 2001 673 681
5. M.A. Bogoyevitch An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection Cardiovascular Research 63 2 2004 208 216
6. M.L. Brines, P. Ghezzi, S. Keenan, D. Agnello, N.C. de Lanerolle, C. Cerami, L.M. Itri, and A. Cerami Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proceedings of the National Academy of Sciences of the United States of America 97 19 2000 10526 10531
7. E. Bryl, J. Mysliwska, A. Debska-Slizien, D. Rachon, B. Bullo, S. Lizakowski, A. Mysliwski, and B. Rutkowski The influence of recombinant human erythropoietin on tumor necrosis factor alpha and interleukin-10 production by whole blood cell cultures in hemodialysis patients Artificial Organs 22 3 1998 177 181
8. Z. Cai, D.J. Manalo, G. Wei, E.R. Rodriguez, K. Fox-Talbot, H. Lu, J.L. Zweier, and G.L. Semenza Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury Circulation 108 1 2003 79 85
9. L. Calvillo, R. Latini, J. Kajstura, A. Leri, P. Anversa, P. Ghezzi, M. Salio, A. Cerami, and M. Brines Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling Proceedings of the National Academy of Sciences of the United States of America 100 8 2003 4802 4806
10. M. Celik, N. Gokmen, S. Erbayraktar, M. Akhisaroglu, S. Konakc, C. Ulukus, S. Genc, K. Genc, E. Sagiroglu, A. Cerami, and M. Brines Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proceedings of the National Academy of Sciences of the United States of America 99 4 2002 2258 2263
11. M. Digicaylioglu, and S.A. Lipton Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades Nature 412 6847 2001 641 647
12. F. Driessler, K. Venstrom, R. Sabat, K. Asadullah, and A.J. Schottelius Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50 Clinical and Experimental Immunology 135 1 2004 64 73
13. H. Fan, B. Sun, Q. Gu, A. Lafond-Walker, S. Cao, and L.C. Becker Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart American Journal of Physiology. Heart and Circulatory Physiology 282 5 2002 H1778 H1786
14. W. Flameng, M. Borgers, W. Daenen, and G. Stalpaert Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man Journal of Thoracic and Cardiovascular Surgery 79 3 1980 413 424
15. N.G. Frangogiannis, L.H. Mendoza, M.L. Lindsey, C.M. Ballantyne, L.H. Michael, C.W. Smith, and M.L. Entman IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury Journal of Immunology 165 5 2000 2798 2808
16. N.G. Frangogiannis, C.W. Smith, and M.L. Entman The inflammatory response in myocardial infarction Cardiovascular Research 53 1 2002 31 47
17. G. Hiasa, M. Hamada, S. Ikeda, and K. Hiwada Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-kappaB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart Japanese Circulation Journal 65 11 2001 984 990
18. A.K. Junk, A. Mammis, S.I. Savitz, M. Singh, S. Roth, S. Malhotra, P.S. Rosenbaum, A. Cerami, M. Brines, and D.M. Rosenbaum Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury Proceedings of the National Academy of Sciences of the United States of America 99 16 2002 10659 10664
19. E.K. Kim, K.B. Kwon, B.C. Shin, E.A. Seo, Y.R. Lee, J.S. Kim, J.W. Park, B.H. Park, and D.G. Ryu Scopoletin induces apoptosis in human promyeloleukemic cells, accompanied by activations of nuclear factor kappaB and caspase-3 Life Sciences 77 7 2005 824 836
20. C. Li, W. Browder, and R.L. Kao Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart American Journal of Physiology 276 2Pt2 1999 H543 H552
21. E. Lipsic, P. van der Meer, R.H. Henning, A.J. Suurmeijer, K.M. Boddeus, D.J. van Veldhuisen, W.H. van Gilst, and R.G. Schoemaker Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion Journal of Cardiovascular Pharmacology 44 4 2004 473 479
22. N. Maulik, H. Sasaki, S. Addya, and D.K. Das Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors FEBS Letters 485 1 2000 7 12
23. E.N. Morgan, E.M. Boyle Jr., W. Yun, J.M. Griscavage-Ennis, A.L. Farr, T.G. Canty Jr., T.H. Pohlman, and E.D. Verrier An essential role for NF-kappaB in the cardioadaptive response to ischemia Annals of Thoracic Surgery 68 2 1999 377 382
24. R. Morishita, T. Sugimoto, M. Aoki, I. Kida, N. Tomita, A. Moriguchi, K. Maeda, Y. Sawa, Y. Kaneda, J. Higaki, and T. Ogihara In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction Nature Medicine 3 8 1997 894 899
25. C.J. Parsa, J. Kim, R.U. Riel, L.S. Pascal, R.B. Thompson, J.A. Petrofski, A. Matsumoto, J.S. Stamler, and W.J. Koch Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts Journal of Biological Chemistry 279 20 2004 20655 20662
26. B. Raychaudhuri, C.J. Fisher, C.F. Farver, A. Malur, J. Drazba, M.S. Kavuru, and M.J. Thomassen Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages Cytokine 12 9 2000 1348 1355
27. T. Rui, Q. Feng, M. Lei, T. Peng, J. Zhang, M. Xu, E.D. Abel, A. Xenocostas, and P.R. Kvietys Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1 Cardiovasc Research 65 3 2005 719 727
28. M.N. Sack, R.M. Smith, and L.H. Opie Tumor necrosis factor in myocardial hypertrophy and ischaemia-an anti-apoptotic perspective Cardiovasc Research 45 3 2000 688 695
29. A.L. Siren, M. Fratelli, M. Brines, C. Goemans, S. Casagrande, P. Lewczuk, S. Keenan, C. Gleiter, C. Pasquali, A. Capobianco, T. Mennini, R. Heumann, A. Cerami, H. Ehrenreich, and P. Ghezzi Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress Proceedings of the National Academy of Sciences of the United States of America 98 7 2001 4044 4049
30. B. Stein, A.S. Baldwin Jr., D.W. Ballard, W.C. Greene, P. Angel, and P. Herrlich Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function EMBO Journal 12 10 1993 3879 3891
31. G. Valen Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure Basic Research in Cardiology 99 1 2004 1 7
32. J.G. Valleio, P. Knuefermann, D.L. Mann, and N. Sivasubramanian Group B Streptococcus induces TNF-alpha gene expression and activation of the transcription factors NF-kappa B and activator protein-1 in human cord blood monocytes Journal of Immunology 165 1 2000 419 425
33. P. Villa, P. Bigini, T. Mennini, D. Agnello, T. Laragione, A. Cagnotto, B. Viviani, M. Marinovich, A. Cerami, T.R. Coleman, M. Brines, and P. Ghezzi Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis Journal of Experimental Medicine 198 6 2003 971 975
34. Z. Yang, B. Zingarelli, and C. Szabo Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury Circulation 101 9 2000 1019 1026
35. C.W. Yang, C. Li, J.Y. Jung, S.J. Shin, B.S. Choi, S.W. Lim, B.K. Sun, Y.S. Kim, J. Kim, Y.S. Chang, and B.K. Bang Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney FASEB Journal 17 12 2003 1754 1755